Cargando…

High nuclear MSK1 is associated with longer survival in breast cancer patients

PURPOSE: Mitogen- and stress-activated kinases (MSKs) are important substrates of the mitogen-activated protein kinase (MAPK)-activated protein kinase family. MSK1 and MSK2 are both nuclear serine/threonine protein kinases, with MSK1 being suggested to potentially play a role in breast cancer cell p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pu, Xuan, Storr, Sarah J., Ahmad, Narmeen S., Rakha, Emad A., Green, Andrew R., Ellis, Ian O., Martin, Stewart G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Article – Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816103/ https://www.ncbi.nlm.nih.gov/pubmed/29327245 http://dx.doi.org/10.1007/s00432-018-2579-7

Ejemplares similares

IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients
por: Ahmad, Narmeen, et al.
Publicado: (2017)

Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival
por: Pu, Xuan, et al.
Publicado: (2016)

Retrospective assessment of cyclin‐dependent kinase 5 mRNA and protein expression and its association with patient survival in breast cancer
por: Saidy, Behnaz, et al.
Publicado: (2020)

CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer
por: Aiyappa‐Maudsley, Radhika, et al.
Publicado: (2022)

Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer
por: Davis, Jillian, et al.
Publicado: (2014)

Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients
por: Martin, Stewart G., et al.
Publicado: (2018)

A retrospective analysis of ezrin protein and mRNA expression in breast cancer: Ezrin expression is associated with patient survival and survival of patients with receptor‐positive disease
por: Storr, Sarah J., et al.
Publicado: (2023)

PP1, PKA and DARPP‐32 in breast cancer: A retrospective assessment of protein and mRNA expression
por: Saidy, Behnaz, et al.
Publicado: (2021)

Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy
por: Zhang, Yimin, et al.
Publicado: (2014)

Dopamine and cAMP-regulated phosphoprotein 32 kDa (DARPP-32) and survival in breast cancer: a retrospective analysis of protein and mRNA expression
por: Kotecha, Shreeya, et al.
Publicado: (2019)

Unravelling transcriptomic complexity in breast cancer through modulation of DARPP-32 expression and signalling pathways
por: Saidy, Behnaz, et al.
Publicado: (2023)

Macrophage-derived interleukin-1beta promotes human breast cancer cell migration and lymphatic adhesion in vitro
por: Storr, Sarah J., et al.
Publicado: (2017)

Emerging Roles of the Mitogen and Stress Activated Kinases MSK1 and MSK2
por: Reyskens, Kathleen M. S. E., et al.
Publicado: (2016)

Msk is required for nuclear import of TGF-β/BMP-activated Smads
por: Xu, Lan, et al.
Publicado: (2007)

Evolving DNA repair synthetic lethality targets in cancer
por: Kulkarni, Sanat, et al.
Publicado: (2022)

Higher miR‐543 levels correlate with lower STK31 expression and longer pancreatic cancer survival
por: Yuan, Weizhong, et al.
Publicado: (2020)

Editorial Seminars in MSK Radiology
por: Simoni, Paolo, et al.
Publicado: (2017)

MSK Ultrasound - An IJSPT Perspective
por: Page, Phil, et al.
Publicado: (2023)

Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival
por: Joseph, Chitra, et al.
Publicado: (2020)

Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments
por: Asperti, Michela, et al.
Publicado: (2021)

Connexin 43 is an independent predictor of patient outcome in breast cancer patients
por: Chasampalioti, Maria, et al.
Publicado: (2018)

Nuclear fascin regulates cancer cell survival
por: Lawson, Campbell D, et al.
Publicado: (2022)

The Impact of Reassurance on Musculoskeletal (MSK) Pain: A Qualitative Review
por: Cheung, Lok, et al.
Publicado: (2021)

AI MSK clinical applications: spine imaging
por: Huber, Florian A., et al.
Publicado: (2021)

The Use of MSK Ultrasound with Quadriceps Muscle Injury
por: Manske, Robert C, et al.
Publicado: (2023)

Using MSK Ultrasound in the Evaluation of Subscapularis Injuries
por: Manske, Robert C., et al.
Publicado: (2023)

Body mass index and breast cancer survival: a Mendelian randomization analysis
por: Guo, Qi, et al.
Publicado: (2017)

DNA damage response markers are differentially expressed in BRCA-mutated breast cancers
por: Aleskandarany, Mohammed, et al.
Publicado: (2015)

Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer
por: Ansari, Rokaya El, et al.
Publicado: (2019)

Age-Related Biology of Early-Stage Operable Breast Cancer and Its Impact on Clinical Outcome
por: Syed, Binafsha M., et al.
Publicado: (2021)

Histological grading of breast cancer on needle core biopsy: the role of immunohistochemical assessment of proliferation
por: Kwok, T’ng Chang, et al.
Publicado: (2010)

The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution
por: Miligy, Islam M., et al.
Publicado: (2019)

Hybrid musculoskeletal (MSK) classes in the age of COVID-19
por: Rahman, N., et al.
Publicado: (2022)

Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair
por: Johnston, Simon J., et al.
Publicado: (2018)

PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer
por: Alfarsi, Lutfi H., et al.
Publicado: (2020)

A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT‐0701 MAPS phase 3 trial
por: Maille, Elodie, et al.
Publicado: (2022)

Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers
por: Ahmad, Dena A. J., et al.
Publicado: (2016)

Expression of Syk and MAP4 proteins in ovarian cancer
por: Zhang, Siwei, et al.
Publicado: (2019)

Chemokine (C‐C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma
por: Sonbul, Sultan N, et al.
Publicado: (2017)

The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer
por: El Ansari, Rokaya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_knq1g7aujecqucda764h4kdltr